Showing results (101-110 of 324) with videos related to
Sort By:
Pageof 33
Cancer Investigation|May 15, 2009
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanomaAgop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.Journal of Hematology & Oncology|September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case reportMarc Uemura, Van A Trinh, Cara Haymaker, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivoChengwen Liu, Carol M Lewis, Yanyan Lou, et al.The New England Journal of Medicine|August 2, 2003
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancerJames C Yang, Leah Haworth, Richard M Sherry, et al.Journal of Translational Medicine|April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.Melanoma Research|November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.The Journal of Clinical Investigation|December 3, 2013
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patientsGeok Choo Sim, Natalia Martin-Orozco, Lei Jin, et al.Cancer Immunology Research|April 19, 2019
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from ImmunotherapyDaniel Johnson, Anisha B Patel, Marc I Uemura, et al.Annals of Surgical Oncology|December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanomaMatthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.Pageof 33